Ying Wu, MD
Rheumatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wu’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126483 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · Shanghai Second Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$97,260
Medicare paid this office $97,260 for 208 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 112 | $35,129 | $166 |
| Return visit (30+ min) | 130 | $28,908 | $117 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 141 | $4,818 | $15 |
| Short return visit (20+ min) | 49 | $4,716 | $75 |
| New patient visit (60+ min) | 21 | $4,395 | $209 |
See all 10 services
| Long return visit (40+ min) | 112 | $35,129 | $166 |
| Return visit (30+ min) | 130 | $28,908 | $117 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 141 | $4,818 | $15 |
| Short return visit (20+ min) | 49 | $4,716 | $75 |
| New patient visit (60+ min) | 21 | $4,395 | $209 |
| New patient visit (45+ min) | 20 | $2,911 | $146 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 17 | $1,727 | $62 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,044 | $61 |
| Complete ultrasound scan of joint | 12 | $1,001 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 22 | $93 | None |
Who their Medicare patients are
208 Original Medicare patients in 2024. Average age 76 · Women 69% · Also on Medicaid 17% · Health risk score 1.25. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 70% · Chronic kidney disease 30% · Diabetes 25% · Coronary heart disease 20% · Atrial fibrillation 19% · Heart failure 14% · Cancer 13% · Depression 13% · COPD 12% · Stroke 5%.
The office billed $326,079, Medicare allowed $127,687 and paid $97,260; for 2,267 services of 37 kinds; $10,414 of it was for drugs given in the office and $86,846 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 208 | 2,267 | 76 | 1.25 | $326,079 | $97,260 |
| 2023 | 185 | 1,052 | 76 | 1.28 | $273,243 | $79,305 |
| 2022 | 191 | 636 | 77 | 1.27 | $205,231 | $65,727 |
| 2021 | 211 | 851 | 74 | 1.25 | $233,194 | $76,951 |
| 2020 | 176 | 1,059 | 74 | 1.32 | $198,940 | $62,277 |
| 2019 | 228 | 744 | 74 | 1.10 | $229,827 | $64,273 |
| 2018 | 187 | 719 | 73 | 1.25 | $249,692 | $61,600 |
| 2017 | 239 | 461 | 67 | 1.58 | $113,901 | $36,251 |
| 2016 | 57 | 87 | 67 | 1.16 | $21,912 | $8,359 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 95 | $31,348 | $166 |
| Return visit (30+ min) | 115 | $26,543 | $111 |
| New patient visit (60+ min) | 22 | $4,473 | $203 |
| New patient visit (45+ min) | 26 | $3,923 | $151 |
| Short return visit (20+ min) | 31 | $2,802 | $74 |
| Complete ultrasound scan of joint | 29 | $2,475 | $52 |
| Aspiration and/or injection of fluid from large joint | 12 | $1,184 | $70 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $78 | None |
2022: 8 services
| Long return visit (40+ min) | 90 | $25,723 | $167 |
| Return visit (30+ min) | 96 | $19,482 | $117 |
| New patient visit (60+ min) | 46 | $9,509 | $207 |
| New patient visit (45+ min) | 31 | $4,467 | $144 |
| Short return visit (20+ min) | 22 | $2,058 | $79 |
| Aspiration and/or injection of fluid from large joint | 13 | $897 | $69 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | $488 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $81 | None |
2021: 7 services
| Return visit (30+ min) | 142 | $36,826 | $113 |
| Long return visit (40+ min) | 64 | $17,839 | $167 |
| New patient visit (60+ min) | 36 | $7,291 | $203 |
| New patient visit (45+ min) | 46 | $6,763 | $147 |
| Short return visit (20+ min) | 18 | $1,950 | $78 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $652 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $77 | None |
2020: 8 services
| Return visit (30+ min) | 128 | $29,650 | $97 |
| New patient visit (45+ min) | 65 | $10,704 | $165 |
| Extended patient service without direct patient contact, first hour | 23 | $2,615 | $114 |
| New patient visit (60+ min) | 14 | $2,270 | $162 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,842 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,736 | $72 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,230 | $59 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $117 | None |
2019: 8 services
| Return visit (30+ min) | 156 | $31,701 | $94 |
| New patient visit (45+ min) | 120 | $16,719 | $139 |
| New patient visit (60+ min) | 21 | $3,755 | $179 |
| Long return visit (40+ min) | 23 | $3,119 | $130 |
| Extended patient service without direct patient contact, first hour | 23 | $2,244 | $98 |
| Aspiration and/or injection of fluid from large joint | 13 | $997 | $59 |
| Aspiration and/or injection of fluid from small joint | 14 | $819 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $89 | None |
2018: 8 services
| Long return visit (40+ min) | 120 | $27,443 | $124 |
| New patient visit (60+ min) | 67 | $10,832 | $162 |
| Return visit (30+ min) | 71 | $9,066 | $91 |
| New patient visit (45+ min) | 38 | $5,328 | $140 |
| Complete ultrasound scan of joint | 19 | $1,915 | $91 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,484 | $59 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 11 | $850 | $57 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 37 | $243 | None |
2017: 8 services
| Return visit (30+ min) | 103 | $12,480 | $81 |
| New patient visit (45+ min) | 59 | $6,919 | $117 |
| Long return visit (40+ min) | 76 | $6,813 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,735 | $161 |
| Return visit (30+ min) | 27 | $1,667 | $56 |
| Short return visit (20+ min) | 17 | $648 | $38 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 13 | $438 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $45 | None |
2016: 2 services
| New patient visit (45+ min) | 28 | $3,753 | $134 |
| Return visit (30+ min) | 12 | $764 | $64 |
Medicaid work
$458 in 2022
Medicaid paid $458 for 13 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 13 | $458 |
| 2022 | 13 | 1 | 12 | $458 |
| 2021 | 13 | 1 | 13 | $340 |
| 2019 | 12 | 1 | 12 | $351 |
| 2018 | 111 | 2 | 19 | $17,443 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 13 | $340 |
2019
| Return visit (30+ min) | 12 | $351 |
2018
| Long return visit (40+ min) | 92 | $13,695 |
| New patient visit (60+ min) | 19 | $3,748 |
Drugs they prescribed that Part D paid
$691,289
Pharmacies billed $691,289 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (24 of 1,016) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.
921 generic and 95 brand-name prescriptions · $691,289 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 37 | $288,710 | $7,803 |
| Cosentyx Sensoready | 11 | $76,283 | $6,935 |
| Kevzara | 14 | $60,238 | $4,303 |
| Mycophenolate Mofetil | 16 | $6,294 | $393 |
| Methotrexate | 120 | $3,807 | $32 |
See all 19 drugs
| Humira(Cf) | 37 | $288,710 | $7,803 |
| Cosentyx Sensoready | 11 | $76,283 | $6,935 |
| Kevzara | 14 | $60,238 | $4,303 |
| Mycophenolate Mofetil | 16 | $6,294 | $393 |
| Methotrexate | 120 | $3,807 | $32 |
| Febuxostat | 17 | $3,011 | $177 |
| Colchicine | 39 | $2,602 | $67 |
| Hydroxychloroquine Sulfate | 49 | $2,337 | $48 |
| Leflunomide | 32 | $2,192 | $69 |
| Prednisone | 242 | $2,125 | $9 |
| Allopurinol | 129 | $1,143 | $9 |
| Diclofenac | 21 | $906 | $43 |
| Celecoxib | 13 | $772 | $59 |
| Pilocarpine | 15 | $540 | $36 |
| Omeprazole | 42 | $377 | $9 |
| Gabapentin | 27 | $295 | $11 |
| Folic Acid | 20 | $238 | $12 |
| Alendronate | 23 | $198 | $9 |
| Tramadol | 13 | $20 | $2 |
Year by year
| 2024 | 1,016 | 189 | 2% (24) | 9% | $691,289 |
| 2023 | 952 | 164 | 2% (18) | None | $535,578 |
| 2022 | 847 | 166 | None | None | $394,763 |
| 2021 | 824 | 159 | 0% (0) | None | $389,107 |
| 2020 | 818 | 148 | None | 15% | $285,131 |
| 2019 | 819 | 158 | None | 15% | $271,360 |
| 2018 | 629 | 163 | 2% (14) | 16% | $190,456 |
| 2017 | 1,132 | 189 | None | 24% | $639,927 |
| 2016 | 238 | 61 | None | 40% | $164,358 |
| 2015 | 431 | 62 | 3% (11) | None | $187,818 |
| 2014 | 448 | 48 | None | None | $61,064 |
| 2013 | 475 | 45 | None | None | $29,269 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Humira(Cf) | 31 | $285,077 | $9,196 |
| Kevzara | 14 | $58,354 | $4,168 |
| Methotrexate | 120 | $5,968 | $50 |
| Leflunomide | 42 | $5,728 | $136 |
| Allopurinol | 118 | $3,288 | $28 |
| Prednisone | 277 | $2,644 | $10 |
| Colchicine | 55 | $2,371 | $43 |
| Hydroxychloroquine Sulfate | 37 | $2,345 | $63 |
| Diclofenac | 31 | $1,429 | $46 |
| Pilocarpine | 13 | $996 | $77 |
| Alendronate | 17 | $305 | $18 |
| Omeprazole | 13 | $227 | $17 |
| Folic Acid | 23 | $96 | $4 |
2022: 14 drugs
| Enbrel Sureclick | 13 | $89,150 | $6,858 |
| Cosentyx | 12 | $78,079 | $6,507 |
| Leflunomide | 45 | $7,445 | $165 |
| Methotrexate | 128 | $6,299 | $49 |
| Prednisone | 244 | $3,571 | $15 |
| Allopurinol | 106 | $3,178 | $30 |
| Hydroxychloroquine Sulfate | 37 | $3,130 | $85 |
| Diclofenac | 27 | $2,043 | $76 |
| Febuxostat | 13 | $1,504 | $116 |
| Mycophenolate Mofetil | 14 | $1,196 | $85 |
| Colchicine | 23 | $797 | $35 |
| Alendronate | 20 | $285 | $14 |
| Omeprazole | 21 | $187 | $9 |
| Folic Acid | 24 | $144 | $6 |
2021: 13 drugs
| Enbrel Sureclick | 20 | $127,592 | $6,380 |
| Xeljanz Xr | 11 | $57,598 | $5,236 |
| Actemra Actpen | 21 | $55,608 | $2,648 |
| Methotrexate | 111 | $6,055 | $55 |
| Hydroxychloroquine Sulfate | 60 | $5,733 | $96 |
| Leflunomide | 28 | $4,800 | $171 |
| Prednisone | 240 | $4,224 | $18 |
| Allopurinol | 117 | $2,943 | $25 |
| Mycophenolate Mofetil | 21 | $2,440 | $116 |
| Colchicine | 17 | $2,074 | $122 |
| Diclofenac | 35 | $1,162 | $33 |
| Folic Acid | 29 | $164 | $6 |
| Omeprazole | 16 | $148 | $9 |
2020: 14 drugs
| Enbrel Sureclick | 15 | $92,555 | $6,170 |
| Enbrel Mini | 13 | $75,519 | $5,809 |
| Xeljanz Xr | 11 | $53,486 | $4,862 |
| Hydroxychloroquine Sulfate | 58 | $8,980 | $155 |
| Methotrexate | 115 | $6,376 | $55 |
| Leflunomide | 20 | $4,584 | $229 |
| Prednisone | 264 | $4,102 | $16 |
| Colchicine | 21 | $3,418 | $163 |
| Allopurinol | 98 | $1,893 | $19 |
| Diclofenac | 58 | $1,440 | $25 |
| Duloxetine | 14 | $678 | $48 |
| Omeprazole | 24 | $236 | $10 |
| Methylprednisolone | 18 | $173 | $10 |
| Alendronate | 17 | $134 | $8 |
2019: 14 drugs
| Enbrel Mini | 12 | $64,460 | $5,372 |
| Hydroxychloroquine Sulfate | 87 | $10,773 | $124 |
| Colchicine | 23 | $5,301 | $230 |
| Methotrexate | 119 | $4,395 | $37 |
| Colcrys | 11 | $3,076 | $280 |
| Leflunomide | 22 | $2,928 | $133 |
| Prednisone | 227 | $2,651 | $12 |
| Allopurinol | 88 | $1,612 | $18 |
| Diclofenac | 38 | $1,053 | $28 |
| Azathioprine | 15 | $437 | $29 |
| Duloxetine | 17 | $268 | $16 |
| Methylprednisolone | 22 | $257 | $12 |
| Omeprazole | 14 | $199 | $14 |
| Meloxicam | 14 | $99 | $7 |
2018: 10 drugs
| Hydroxychloroquine Sulfate | 120 | $16,672 | $139 |
| Leflunomide | 44 | $11,209 | $255 |
| Methotrexate | 82 | $3,658 | $45 |
| Prednisone | 161 | $2,004 | $12 |
| Diclofenac | 16 | $711 | $44 |
| Azathioprine | 12 | $674 | $56 |
| Allopurinol | 18 | $285 | $16 |
| Sulfasalazine | 11 | $277 | $25 |
| Methylprednisolone | 11 | $151 | $14 |
| Meloxicam | 13 | $114 | $9 |
2017: 18 drugs
| Humira | 61 | $273,844 | $4,489 |
| Enbrel | 26 | $114,295 | $4,396 |
| Enbrel Sureclick | 19 | $87,374 | $4,599 |
| Hydroxychloroquine Sulfate | 313 | $54,573 | $174 |
| Humira | 12 | $52,344 | $4,362 |
| Leflunomide | 109 | $18,083 | $166 |
| Methotrexate | 131 | $10,124 | $77 |
| Prednisone | 194 | $2,468 | $13 |
| Azathioprine | 35 | $1,515 | $43 |
| Sulfasalazine | 49 | $1,222 | $25 |
| Mycophenolate Mofetil | 11 | $612 | $56 |
| Celecoxib | 11 | $373 | $34 |
| Methylprednisolone | 12 | $211 | $18 |
| Naproxen | 26 | $210 | $8 |
| Pantoprazole | 12 | $111 | $9 |
| Gabapentin | 12 | $91 | $8 |
| Ibu | 12 | $77 | $6 |
| Meloxicam | 14 | $56 | $4 |
2016: 7 drugs
| Enbrel | 14 | $55,329 | $3,952 |
| Hydroxychloroquine Sulfate | 46 | $7,183 | $156 |
| Methotrexate | 34 | $2,571 | $76 |
| Leflunomide | 16 | $1,912 | $120 |
| Mycophenolate Mofetil | 13 | $1,083 | $83 |
| Azathioprine | 12 | $740 | $62 |
| Prednisone | 48 | $521 | $11 |
2015: 9 drugs
| Orencia | 13 | $41,866 | $3,220 |
| Hydroxychloroquine Sulfate | 59 | $8,900 | $151 |
| Mycophenolate Mofetil | 30 | $4,926 | $164 |
| Methotrexate | 62 | $4,431 | $71 |
| Leflunomide | 17 | $2,144 | $126 |
| Azathioprine | 28 | $1,696 | $61 |
| Prednisone | 76 | $1,169 | $15 |
| Simvastatin | 11 | $57 | $5 |
| Meloxicam | 12 | $52 | $4 |
2014: 14 drugs
| Lantus | 11 | $10,708 | $973 |
| Novolog | 11 | $7,597 | $691 |
| Methotrexate | 11 | $646 | $59 |
| Prednisone | 37 | $479 | $13 |
| Levothyroxine | 20 | $259 | $13 |
| Hydroxychloroquine Sulfate | 14 | $245 | $18 |
| Lisinopril | 35 | $178 | $5 |
| Simvastatin | 27 | $168 | $6 |
| Carvedilol | 14 | $129 | $9 |
| Metformin | 17 | $115 | $7 |
| Metoprolol | 26 | $85 | $3 |
| Losartan | 12 | $76 | $6 |
| Amlodipine Besylate | 11 | $51 | $5 |
| Hydrochlorothiazide | 16 | $46 | $3 |
2013: 15 drugs
| Lantus | 18 | $6,651 | $370 |
| Novolog | 14 | $5,451 | $389 |
| Pantoprazole | 20 | $397 | $20 |
| Simvastatin | 42 | $221 | $5 |
| Hydralazine | 13 | $202 | $16 |
| Lisinopril | 41 | $190 | $5 |
| Losartan | 20 | $147 | $7 |
| Metformin | 22 | $144 | $7 |
| Carvedilol | 18 | $118 | $7 |
| Clopidogrel | 16 | $108 | $7 |
| Levothyroxine | 14 | $100 | $7 |
| Amlodipine Besylate | 11 | $94 | $9 |
| Metoprolol | 17 | $81 | $5 |
| Hydrochlorothiazide | 31 | $78 | $3 |
| Omeprazole | 11 | $72 | $7 |
Money from drug and device companies
$155 in 2025
| 2025 | 2 | 3 | None | $155 |
| 2024 | 3 | 6 | None | $314 |
| 2023 | 5 | 9 | None | $470 |
| 2022 | 5 | 13 | None | $317 |
| 2021 | 2 | 3 | None | $50 |
| 2019 | 3 | 11 | None | $351 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | None | $124 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $31 | 2 payments
|
See all 3 published payments
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Cosentyx | $15 |
| Abbvie | Meals · 2025-04-10 | None | $124 |
| Novartis Pharmaceuticals | Meals · 2025-03-12 | Cosentyx | $17 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $314
| Abbvie | Rinvoq | $125 | 1 payment
|
| Ucb | None | $116 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $73 | 4 payments
|
2023: $470
| AbbVie | Rinvoq | $140 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $125 | 1 payment
|
| Ucb | Cimzia | $125 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $62 | 3 payments
|
| Janssen Biotech | Tremfya | $18 | 1 payment
|
2022: $317
| Ucb | None | $88 | 1 payment
|
| Janssen Biotech | Tremfya | $77 | 4 payments
|
| Abbvie | Rinvoq | $55 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $53 | 4 payments
|
| Aurinia Pharma U.S. | Lupkynis | $45 | 1 payment
|
2021: $50
| Janssen Biotech | Tremfya | $38 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $11 | 1 payment
|
2019: $351
| Novartis Pharmaceuticals | Cosentyx | $168 | 4 payments
|
| AbbVie | Humira | $167 | 6 payments
|
| Pfizer | Xeljanz | $16 | 1 payment
|
Professional record
- NPI
- 1225329303
- Licence
- CA A126483California A126483: Current · expires 2027-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2011-04-25
- NPI last updated
- 2018-09-13
This is when the NPI record was last certified, not a medical board exam.